ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 29-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 1.30 3.52 58.03 16.37 25.73 21.34
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 0.32 1.71 52.41 14.18 22.63 15.27

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 58.03 16.37 25.73 1.95 3,834.82
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 51.80 14.27 24.60 1.82 7,132.82
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 45.62 15.37 24.89 2.01 2,667.21
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 48.75 16.21 26.75 2.00 2,343.94
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 49.40 14.05 25.40 1.99 2,236.01
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 50.77 12.66 22.86 2.33 943.34

Fund Holdings as on 30-April-2024

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Lupin Ltd.

  • Cipla Ltd.

  • Mankind Pharma Ltd

  • Gland Pharma Ltd.

  • Fortis Healthcare Ltd.

  • Alkem Laboratories Ltd.

  • TREPS

  • Astrazeneca Pharma India Ltd.

  • Atul Ltd.

  • FDC Ltd.

  • Shilpa Medicare Ltd.

  • Zydus Lifesciences Ltd.

  • HDFC Life Insurance Company Ltd.

  • Vijaya Diagnostic Centre Pvt Ltd.

  • Healthcare Global Enterprises Ltd.

  • Pfizer Ltd.

  • Syngene International Ltd.

  • Star Health & Allied Insurance

  • Krsnaa Diagnostics Ltd.

  • Thyrocare Technologies Ltd.

  • Windlas Biotech Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • Navin Fluorine International Ltd.

  • Blue Jet Healthcare Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Laxmi Organic Industries Ltd.

  • Piramal Pharma Ltd.

  • Advanced Enzyme Technologies Ltd.

  • Galaxy Surfactants Ltd.

  • Wockhardt Ltd.

  • Procter & Gamble Health Ltd.

  • Aarti Pharmalabs Ltd

  • Vinati Organics Ltd.

  • Glenmark Life Sciences Ltd

  • Cash Margin - Derivatives

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Insurance

  • Miscellaneous

  • Business Support

  • Household & Personal Products

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹3,834.82 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.06(0.19%)yesterday to ₹31.24.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100